- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00672750
A Retrospective Review Of Outcomes Following Laparoscopic Myomectomy (retromyo)
January 24, 2017 updated by: Charles E Miller MD, The Advanced Gynecologic Surgery Institute
This will be a retrospective review of approximately 900 patients who have undergone laparoscopic myomectomy since 1999.
patients will be contacted by phone and surveyed.
All patients who have had laparoscopic myomectomy will be included.
Only those not wishing to take part in the survey will be excluded.
The data will then be compiled for statistical analysis , looking at pain, bleeding and subsequent fertility.
Study Overview
Status
Terminated
Conditions
Detailed Description
Patients will be called and surveyed using a survey tool.
They will be asked about what factors lead them to have surgery and then was their issue resolved after surgery.
Study Type
Observational
Enrollment (Actual)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Naperville, Illinois, United States, 60540
- Advanced Gynecologic Surgery Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 70 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Private patients of Dr Charles Miller who have undergone laparoscopic myomectomy since 1999
Description
Inclusion Criteria:
- All patients who are willing to be surveyed
Exclusion Criteria:
Those patients who are not willing to answer the survey will be excluded
- Those patients who are unable to be contacted( ie; moved) will be excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
I
Patients of Dr C Miller who have undergone laparoscopic myomectomy from 1999- to present
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
That patients who had pain prior to laparoscopic myomectomy will have less pain in 75% of the cases
Time Frame: since 1999
|
since 1999
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
That patients who had menorrhagia prior to laparoscopic myomectomy would see a reduction after surgery 75% of the time
Time Frame: since 1999
|
since 1999
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Charles E Miller, MD, Advanced Gynecologic Surgery Institute
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Primary Completion (Actual)
September 16, 2016
Study Completion (Actual)
September 16, 2016
Study Registration Dates
First Submitted
May 1, 2008
First Submitted That Met QC Criteria
May 5, 2008
First Posted (Estimate)
May 6, 2008
Study Record Updates
Last Update Posted (Estimate)
January 26, 2017
Last Update Submitted That Met QC Criteria
January 24, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 23597
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.